Inventor · disambiguated record
Patrick Bauerle
Also filed as: BAEUERLE PATRICK · BAUERLE PATRICK · BÄUERLE PATRICK
7 granted patents·5 pending applications·373 citations·filing 2001–2021
88Inventor score
Top patents by PatentIndex Score
12 records- 0196US7635472B2Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disordersMICROMET AG·Filed 2004·Granted Dec 22, 2009·158 cites·8 claims
- 0295US8076459B2Multispecfic deimmunized CD3-bindersHOFMEISTER ROBERT·Filed 2004·Granted Dec 13, 2011·97 cites·31 claims
- 0394US9102736B2Multispecific deimmunized CD3-bindersHOFMEISTER ROBERT·Filed 2011·Granted Aug 11, 2015·37 cites·37 claims
- 0492US8784821B1Human-anti-human cd3 binding moleculesKUFER PETER·Filed 2004·Granted Jul 22, 2014·63 cites·23 claims
- 0589US10662243B2Dosage regimen for administering a CD19XCD3 bispecific antibodyAMGEN RES MUNICH GMBH·Filed 2014·Granted May 26, 2020·6 cites·20 claims
- 0686US8790645B2Pharmaceutical composition comprising a bispecific antibody for EpCAMKUFER PETER·Filed 2011·Granted Jul 29, 2014·10 cites·13 claims
- 0771US7964707B2Anti-IL2 antibodiesMICROMET AG·Filed 2006·Granted Jun 21, 2011·2 cites·19 claims
- 0869US2022088196A1Means and Methods for Treating Tumorous DiseasesAMGEN RES MUNICH GMBH·Filed 2021·Application pending·0 cites
- 0962US2019002568A1Bispecific fc moleculesAMGEN INC·Filed 2018·Application pending·0 cites
- 1054US2005176028A1Deimmunized binding molecules to CD3Filed 2004·Application pending·0 cites
- 1145US2007122852A1Method for identifying antigen specific b cellsMICROMET AG·Filed 2003·Application pending·0 cites
- 1233US2004048816A1Restenosis treatmentFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →